title: [Drug-eluting stents: indications, limits and future development].
authors.affiliation: Service de cardiologie, hôpital Charles Nicolle, Rouen.
authors.forename: B
authors.initials: B
authors.lastname: Chevalier
authors.forename: D
authors.initials: D
authors.lastname: Blanchard
authors.forename: J
authors.initials: J
authors.lastname: Berland
authors.forename: D
authors.initials: D
authors.lastname: Carrié
authors.forename: M
authors.initials: M
authors.lastname: Gilard
authors.forename: M
authors.initials: M
authors.lastname: Hanssen
authors.forename: Y
authors.initials: Y
authors.lastname: Louvard
authors.forename: H
authors.initials: H
authors.lastname: Eltchaninoff
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use; D020099:Coated Materials, Biocompatible; D003324:Coronary Artery Disease / Q000601:surgery*; D004867:Equipment Design; D006801:Humans; D017239:Paclitaxel / Q000008:administration & dosage / Q000627:therapeutic use; D020123:Sirolimus / Q000008:administration & dosage / Q000627:therapeutic use; D015607:Stents / Q000009:adverse effects
chemical_list: D000900:Anti-Bacterial Agents; D020099:Coated Materials, Biocompatible; D017239:Paclitaxel; D020123:Sirolimus